A carregar...

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Sixteen female patients with diabetes-associated osteoarthritis (DAOA) participated in an openlabel, randomized, cross-over study. The mean patients’ age was 65.5 (±5.4) years, the patients were obese (mean body mass index, 35.8±5.7 kg/m2 ). They suffered from durable osteoarthritis (14.5±7.6 years)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: V. S. Shirinsky, E. V. Kazygasheva, N. Yu. Kalynovskaya, I. V. Shirinsky
Formato: Artigo
Idioma:Russo
Publicado em: SPb RAACI 2017-05-01
Colecção:Medicinskaâ Immunologiâ
Assuntos:
Acesso em linha:https://www.mimmun.ru/mimmun/article/view/1219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!